Literature DB >> 30439443

Intracranial atherosclerotic disease.

Yuan Wang1, Ran Meng1, Gang Liu1, Catherine Cao2, Fenghua Chen2, Kunlin Jin3, Xunming Ji4, Guodong Cao5.   

Abstract

Intracranial atherosclerosis (ICAS) is a progressive pathological process that causes progressive stenosis and cerebral hypoperfusion and is a major cause of stroke occurrence and recurrence around the world. Multiple factors contribute to the development of ICAS. Angiography imaging techniques can improve the diagnosis of and the selection of appropriate treatment regimens for ICAS. Neither aggressive medication nor endovascular interventions can eradicate stroke recurrence in patients with ICAS. Non-pharmacological therapies such as remote ischemic conditioning and hypothermia are emerging. Comprehensive therapy with medication in combination with endovascular intervention and/or non-pharmacological treatment may be a potential strategy for ICAS treatment in the future. We summarized the epidemiology, pathophysiological mechanisms, risk factors, biomarkers, imaging and management of ICAS.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Angiography; Biomarker; Diagnosis; Intracranial atherosclerosis; Ischemic conditioning; Treatment

Mesh:

Year:  2018        PMID: 30439443      PMCID: PMC6363839          DOI: 10.1016/j.nbd.2018.11.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  169 in total

Review 1.  Current diagnosis and management of symptomatic intracranial atherosclerotic disease.

Authors:  Shyam Prabhakaran; Jose G Romano
Journal:  Curr Opin Neurol       Date:  2012-02       Impact factor: 5.710

2.  Middle cerebral artery intraplaque hemorrhage: prevalence and clinical relevance.

Authors:  Wei-Hai Xu; Ming-Li Li; Shan Gao; Jun Ni; Ming Yao; Li-Xin Zhou; Bin Peng; Feng Feng; Zheng-Yu Jin; Li-Ying Cui
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

3.  Matrix metalloproteinases increase very early during experimental focal cerebral ischemia.

Authors:  J H Heo; J Lucero; T Abumiya; J A Koziol; B R Copeland; G J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  1999-06       Impact factor: 6.200

Review 4.  The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis.

Authors:  E T H Yeh; B V Khan
Journal:  J Thromb Haemost       Date:  2006-09-08       Impact factor: 5.824

Review 5.  Cilostazol: an antiplatelet agent for the neurointerventionist?

Authors:  P Bhogal; P A Brouwer; H L D Makalanda
Journal:  J Neurointerv Surg       Date:  2014-12-19       Impact factor: 5.836

6.  High expression of ubiquitin conjugates and NF-κB in unstable human intracranial atherosclerotic plaques.

Authors:  Ruihong Sun; Ling Xiao; Shurong Duan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

7.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.

Authors:  Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan
Journal:  N Engl J Med       Date:  2015-04-17       Impact factor: 91.245

8.  Limb remote ischemic postconditioning protects against focal ischemia in rats.

Authors:  Chuancheng Ren; Zhimin Yan; Dingtai Wei; Xuwen Gao; Xiaoyuan Chen; Heng Zhao
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

Review 9.  Adipokines and stroke: a review of the literature.

Authors:  C Savopoulos; K Michalakis; M Apostolopoulou; A Miras; A Hatzitolios
Journal:  Maturitas       Date:  2011-09-29       Impact factor: 4.342

Review 10.  The role of remote ischemic preconditioning in the treatment of atherosclerotic diseases.

Authors:  Spyros N Vasdekis; Dimitrios Athanasiadis; Andreas Lazaris; Georgios Martikos; Aristeidis H Katsanos; Georgios Tsivgoulis; Anastasios Machairas; Theodoros Liakakos
Journal:  Brain Behav       Date:  2013-08-30       Impact factor: 2.708

View more
  15 in total

1.  Periodontal Disease Association with Large-Artery Atherosclerotic Stroke.

Authors:  Rachel Mascari; Alexandra Vezzeti; Christine Orofino; Amanda Byrd; David Hicklin; Cynthia Nichols; James Curtis; Souvik Sen
Journal:  J Neurol Disord Stroke       Date:  2021-05-19

2.  Circulating MicroRNAs as Potential Biomarkers for Ischemic Stroke in Patients with Asymptomatic Intracranial Artery Stenosis.

Authors:  Jia Zhang; Yuan Shen; Kaijiang Kang; Jinxi Lin; Anxin Wang; Shangzhi Li; Shouling Wu; Xingquan Zhao; Qian Zhang
Journal:  Cell Mol Neurobiol       Date:  2022-07-28       Impact factor: 4.231

3.  Correlation of the characteristics of symptomatic intracranial atherosclerotic plaques with stroke types and risk of stroke recurrence: a cohort study.

Authors:  Huayun Jiang; Kaixuan Ren; Tiantian Li; Chengqun Qian; Shenchu Gong; Tianle Wang; Li Zhu
Journal:  Ann Transl Med       Date:  2022-06

4.  Sex Differences in Intracranial Atherosclerotic Plaques Among Patients With Ischemic Stroke.

Authors:  Xuejiao Yan; Min Tang; Jie Gao; Lihui Wang; Ling Li; Niane Ma; Xiaorui Shi; Xiaoyan Lei; Xiaoling Zhang
Journal:  Front Cardiovasc Med       Date:  2022-06-30

5.  Preventive effects of ginseng against atherosclerosis and subsequent ischemic stroke: A randomized controlled trial (PEGASUS trial).

Authors:  Boseong Kwon; Yunsun Song; Joong-Goo Kim; Dongwhane Lee; Sang-Hun Lee; Young-Keol Cho; Jong S Kim; Dae Chul Suh
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

Review 6.  Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options.

Authors:  Marina Petrova Krasteva; Kui Kai Lau; Pasquale Mordasini; Anderson Chun On Tsang; Mirjam Rachel Heldner
Journal:  Adv Ther       Date:  2020-04-08       Impact factor: 3.845

7.  Molecular Biomarkers Associated with Early-Onset Symptomatic Intracranial Atherosclerosis.

Authors:  Yunfang Luo; Fang Yu; Xianjing Feng; Di Liao; Yuanlin Ying; Xi Li; Qin Huang; Zeyu Liu; Minping Wei; Tingting Zhao; Lin Zhang; Ruxin Tu; Jian Xia
Journal:  Clin Interv Aging       Date:  2021-06-01       Impact factor: 4.458

8.  Links Between Adiponectin and Dementia: From Risk Factors to Pathophysiology.

Authors:  RuiJuan Chen; Yi Shu; Yi Zeng
Journal:  Front Aging Neurosci       Date:  2020-01-08       Impact factor: 5.750

Review 9.  Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration.

Authors:  Alexander Lin; Niridu Jude Peiris; Harkirat Dhaliwal; Maria Hakim; Weizhen Li; Subramaniam Ganesh; Yogambha Ramaswamy; Sanjay Patel; Ashish Misra
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

Review 10.  Review on Laser Technology in Intravascular Imaging and Treatment.

Authors:  Jing Li; Ce Shang; Yao Rong; Jingxuan Sun; Yuan Cheng; Boqu He; Zihao Wang; Ming Li; Jianguo Ma; Bo Fu; Xunming Ji
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.